Celentyx Ltd | Immunology CRO
  • Home
  • Immunology Assays
    • B Cells
    • Haemolysis Testing
    • Human microglia
    • Macrophages/Monocytes
    • Neutrophils/Granulocytes
    • Phagocytosis Assays
    • Regulatory T cells
    • Spheroid Killing Assays
    • Suppression Assays
    • T Cells Activation Assays
    • T Cell Exhaustion Assays
    • Tumour infiltrating lymphocyte (TIL) and dissociated tumour cell assays
    • Tumour Cell Killing
  • Therapeutic Area
    • Autoimmunity & Inflammation
    • COVID-19
    • Fibrosis
    • Immuno-oncology
    • Neuroinflammation
  • Services
    • Assays on Patient Cells
    • Bespoke Services & Assay Development
    • CyTOF
    • ELISA
    • ELISpot
    • ELLA
    • Flow Cytometry
    • Imaging: High-content
    • Luminex
    • Phosphoflow
    • Seahorse Metabolic Assays
  • About
    • People
    • Publications
    • News
    • Careers
  • Contact

Monocytes & Macrophages

Home > Immunology Assays > Macrophages/Monocytes

Assays for measuring monocyte and macrophage activation, cytokine release, migration, phagocytosis and polarization

Macrophages and monocytes are key effector cells of the innate immune system and are largely responsible for engulfing dying cells and pathogens. Macrophage dysregulation can be a key contributor to autoimmune, inflammatory and fibrotic diseases as well as cancer. Tissue resident macrophage populate organs early in development and may also be replenished by infiltrating monocytes which subsequently differentiate. Specialisedtissue resident macrophage populations include microglia in the brain and Kupffer cells in the liver.

Macrophages and monocytes display considerable heterogeneity, and whilst classically have been divided into ‘M1’ (‘pro-inflammatory’) and ‘M2’ (‘pro-resolution/anti-inflammatory’, ‘pro-fibrotic’) phenotypes, single cell studies have enabled identification of discrete phenotypes associated with function and/or location such as plaque associated macrophages, synovial tissue macrophages, tumour-associated macrophages, colitis-associated macrophages and scar-associated macrophages.

Celentyx offers a range of established assays which support the development of therapeutics targeting macrophages. These range from comprehensive phenotyping studies performed using spectral 
flow cytometry and using a range of polarizing conditions (including those to study ‘M1’ and ‘M2’ phenotypes), to functional studies that quantify key macrophage functions such as phagocytosis and cytokine release. These studies can be performed using macrophages derived from human monocytes and also on cells isolated from human resected tissue. 

Assays may be suitable for evaluating modulators of ABCA7, adenosine receptors, Arginase, CD33, CD80, CD86, CD209, FcgRs, IDO, NLRP3, P2RX7, P2RY12, PI3K, TLRs, SIRPa, STAT3, STING, and others.

​

Selected publication list...
Further Immunology Assays
B Cells
Haemolysis Testing
​Human Microglia
​Neutrophils/Granulocytes
​Phagocytosis Assays
Regulatory T cells​
Spheroid Killing Assays​
Suppression Assays​​​​​​
​T Cell Activation Assays
​T Cell Exhaustion Assays
Tumour infiltrating lymphocyte (TIL) and dissociated tumour cell assays​
Tumour Cell Killing Assays


Phagocytosis 
Phagocytosis
• Phagocytosis of tumor cells can be an important mechanism of tumorsurveillance or antibody-dependent cytotoxicity.

• Modulators that affect the capture of tumour cells by phagocytic cells can be identified by high-throughput confocal microscopy.
Phagocytosis of tumour cells

Assessment of Monocyte Subsets
Myeloid compartments from patient tumours may show altered responses to stimuli.
Assessment of Monocyte Subsets
Subsets of monocytes may play different roles in health and disease.
Assessment of Monocyte Subsets

Microglia - the macrophages of the brain
Picture
Also available monocyte-derived microglia (MDMi) generated from the peripheral blood monocytes of patients with neurodegenerative or psychiatric diseases provide an alternative approach:
Picture

Monocytes and Macrophages in Disease

Given the central role of macrophages in both the clearance of pathogens and tissue remodeling, any deviation in their phenotype, especially when maintained in a chronic inflammatory state, can result in significant tissue pathology. The presence of activated macrophages is thought to be pathogenic in a number of diseases including multiple sclerosis, where they strip myelin from the neuron sheath, chronic obstructive pulmonary disease, rheumatoid arthritis, cancer and atherosclerosis.    
Learn more about Celentyx Ltd's access to patient samples...

FIND US

Celentyx Ltd
Birmingham Research Park
97 Vincent Drive
Birmingham
B15 2SQ
United Kingdom
Celentyx Innovation Lab
BioEscalator Innovation Building
Roosevelt Drive
Oxford
​OX3 7FZ
United Kingdom

    CONTACT US

Submit
Web Hosting by Bluehost
  • Home
  • Immunology Assays
    • B Cells
    • Haemolysis Testing
    • Human microglia
    • Macrophages/Monocytes
    • Neutrophils/Granulocytes
    • Phagocytosis Assays
    • Regulatory T cells
    • Spheroid Killing Assays
    • Suppression Assays
    • T Cells Activation Assays
    • T Cell Exhaustion Assays
    • Tumour infiltrating lymphocyte (TIL) and dissociated tumour cell assays
    • Tumour Cell Killing
  • Therapeutic Area
    • Autoimmunity & Inflammation
    • COVID-19
    • Fibrosis
    • Immuno-oncology
    • Neuroinflammation
  • Services
    • Assays on Patient Cells
    • Bespoke Services & Assay Development
    • CyTOF
    • ELISA
    • ELISpot
    • ELLA
    • Flow Cytometry
    • Imaging: High-content
    • Luminex
    • Phosphoflow
    • Seahorse Metabolic Assays
  • About
    • People
    • Publications
    • News
    • Careers
  • Contact